DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20160804

Comparison of clonidine and dexmedetomidine as an adjuvant to bupivacaine in supraclavicular brachial plexus block for upper limb orthopedic procedures

Rajaclimax Kirubahar, Bose Sundari, Vijay Kanna, Kanakasabai Murugadoss

Abstract


Background: Supraclavicular brachial plexus block is used commonly for upper limb orthopedic procedures. Among the adjuvants used to improve the quality of block induced by bupivacaine the alpha 2 agonists are of new interest. This study was done to compare dexmedetomidine and clonidine as adjuvants to bupivacaine for supraclavicular brachial plexus block in upper limb orthopedic surgeries.

Methods: 60 ASA I/II patients aged between 20 and 50 years undergoing upper limb orthopedic procedures were selected and divided into two groups of 30 each. Group C received 35 ml of 0.375% Bupivacaine and clonidine 2µg/kg while Group D received 35 ml of 0.375% bupivacaine and dexmedetomidine 2 µg/kg. Onset time to sensory and motor blockade, vitals, complete duration of motor and sensory block, total duration of analgesia and side effects were noted.

Results: The mean time of onset for sensory block and motor block in Group D was lower when compared to Group C. Except at 5th minute the pulse rate and mean arterial pressure were lower in Group D when compared to Group C. The mean time for total duration of sensory block and motor block was more in Group D when compared to Group C. The total duration of analgesia was higher in Group D than in Group C.

Conclusions: The addition of dexmedetomidine to bupivacaine during supraclavicular brachial plexus block produces a shorter onset of time to sensory and motor block with prolonged duration of analgesia when compared to clonidine added to bupivacaine.

 


Keywords


Dexmedetomidine, Clonidine, Supraclavicular brachial plexus block

Full Text:

PDF

References


Malinzak EB, Gan TJ. Regional anesthesia for vascular access surgery. Anesth Analg. 2009;109(3):976-80.

Förster, JG, Rosenberg PH. Clinically useful adjuvants in regional anesthesia. Current Opinion in Anesthesiology. 2003;16:477-86.

Gabriel JS. Gordin V. Alpha 2 agonists in regional anesthesia and analgesia. Current Opinion in Anesthesiology. 2001;6:751-2.

Jadon A, Panigrahi MR, Parida SS, Chakraborty S, Agrawal PS, Panda A. Buprenorphine improves the efficacy of bupivacaine in nerve plexus block: A double blind randomized evaluation in subclavian perivascular brachial block. J Anaesth Clin Pharmacol. 2009;25(2):207-10.

O'Donnell BD, Iohom G. An estimation of the minimum effective anesthetic volume of 2% lidocaine in ultrasound-guided axillary brachial plexus block. Anesthesiology. 2009;111:25-9.

Swami SS, Keniya VM, Ladi SD, Rao R. Comparison of dexmedetomidine and clonidine (α2 agonist drugs) as an adjuvant to local anaesthesia in supraclavicular brachial plexus block: A randomised double-blind prospective study. Indian J Anaesth. 2012;56:243-97.

Gandhi R, Shah A, Patel I. Use of dexmedetomidine

along with bupivacaine for brachial plexus block. Natl J Med Res. 2012;2(1):67-9.

Agarwal S. Dexmedetomidine prolongs the effect of bupivacaine in supraclavicular brachial plexus block. J Anaesthesiol clin Pharmacol. 2014;30:36-40.

Ammar AS, Mahmoud KM. Ultrasound-guided single injection infraclavicular brachial plexus block using bupivacaine alone or combined with dexmedetomidine for pain control in upper limb surgery: a prospective randomized controlled trial. Saudi J Anaesth. 2012;6:109-14.

Kaygusuz K. Effects of adding dexmedetomidine to levobupivacaine in axillary brachial plexus block. Curr Ther Res Clin Exp. 2012;73:103-11.

Ahmad Dar F, Najar MR, Jan N. Dexmedetomidine Added to Ropivacaine Prolongs Axillary Brachial Plexus Block. International journal of biomedical and advance research. 2013;4(10):713-8.

Solanki S, Bharti N, Batra Y, Jain A, Kumar P, Nikhar S. The analgesic effect of intrathecal dexmedetomidine or clonidine, with bupivacaine, in trauma patients undergoing lower limb surgery: a randomised, double-blind study. Anaesth Intensive Care. 2013;41(1):46-5.